Dupuytren's disease fibromatosis palmaris
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Groningen
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Presence of primary Dupuytren's disease
Exclusion criteria
Exclusion criteria: Patients who are incapable of giving informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The natural course of progression of Dupuytren*s disease, defined as the increase in size of nodules and cords in millimetres and/or increase of total passive extension deficit in degrees and/or a change in echogenicity of the nodules and/or a change in nodule hardness. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Patient questionnaire on functional complaints (URAM-scale DLV) - presence and course of recurrent disease, defined as the development or change iof nodules and cords in millimetres and/or increase of total passive extension deficit in degrees. - Echogenicity of the nodules - Hardness of the nodules | — |
Countries
Netherlands
Outcome results
None listed